Qualification of impurities based on metabolite dataLars Weidolf, Bruce A. Trela, Martin A. Hayes et al.|Regulatory Toxicology and Pharmacology|2019Cited by 20
Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakesDavid J. Ponting, Robert Thomas, Andreas Czich et al.|Regulatory Toxicology and Pharmacology|2024Cited by 13
Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessmentsAlex Cayley, Susanne Glowienke, Raphael Nudelman et al.|Regulatory Toxicology and Pharmacology|2023Cited by 6